Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 55%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is projected to continue its strong financial performance, as evidenced by its recent positive revisions to revenue and EBITDA guidance for fiscal year 2026. The company has established partnerships with numerous large employers and health plans and focuses on improving health outcomes and reducing costs. Despite potential competition and risks, the company is actively expanding its platform and investing in new capabilities and partnerships for future growth.

Bears say

Omada Health is a rapidly growing platform that seeks to empower individuals to make positive health changes through personalized, virtual care between doctor's visits. However, despite its robust membership growth and potential for continued success, it faces competition from a growing number of other virtual care and disease management platforms, as well as a complex and crowded landscape of anti-obesity and GLP-1 medications. Additionally, Omada's relatively high valuation compared to its peers raises concerns about its sustainability in the long-term.

OMDA has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 55% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 11 analysts, OMDA has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.